Subscribe to Our Contact List
BuyandBill.com Free Access Policy
BuyandBill.com was started almost ten years ago. Our goal is ensuring that payers and providers of pharmaceutical products have access to the latest drug pricing information without subscription fees.
Accessing and aggregating multiple sources of drug pricing and coding information and publishing it on BuyandBill.com is an expensive and time-consuming endeavor.
BuyandBill.com is an advertising supported platform. Our sponsors and partners provide generous support in the hopes of reaching the prescribers, providers and payers of their products with valuable product related news and updates.
In April 2023, we implemented a subscription fee for those BuyandBill.com users that do not provide an advertising benefit to our sponsors. This includes those users that have opted out of or do not open our marketing emails.
With that in mind, we are launching the following Free Basic Access usage policy for payers and providers.
To maintain free Basic access, we will require all users to do the following:
- Opt-in or resubscribe to our marketing email list.
- Open at least one marketing email per month.
If you do not wish to participate in our program, your account will be downgraded to Free status and you may pay for any subscription level that you would like. Please note that if your organization has a spam filter that blocks our emails, you may need to add BuyandBill.com to your safe senders list.
Thank you for using our site!
Ian Kaswan
Founder and Owner
BuyandBill.com